CDEK
← All drugs Report issue

cudc-101

Small moleculeexperimental

Clinical trial activity

4 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Aug 1, 2008 (NCT00728793)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1
Mol. weight
434.5 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-n-hydroxyheptanamide
  • cudc101
  • cudc 101
  • cudc-101
  • cudc-101
  • cudc-101
  • cudc-101
  • cudc-101

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01702285Phase 1Sep 1, 2012Curis
NCT01384799Phase 1Nov 1, 2011Curis
NCT01171924Phase 1Jul 1, 2010Curis
NCT00728793Phase 1Aug 1, 2008Curis, South Texas Accelerated Research Therapeutics
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
CurisFor profit4412008
South Texas Accelerated Research TherapeuticsFor profit1012008
2 organizations
Page 1 / 1